BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25773908)

  • 41. Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.
    Otsuru T; Kobayashi S; Wada H; Takahashi T; Gotoh K; Iwagami Y; Yamada D; Noda T; Asaoka T; Serada S; Fujimoto M; Eguchi H; Mori M; Doki Y; Naka T
    Cancer Sci; 2019 Mar; 110(3):985-996. PubMed ID: 30575211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer.
    Recouvreux MV; Moldenhauer MR; Galenkamp KMO; Jung M; James B; Zhang Y; Lowy A; Bagchi A; Commisso C
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32510550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of Transforming Growth Factor-β (TGF-β) Signaling by Scutellaria baicalensis and Fritillaria cirrhosa Extracts in Endometrial Cancer.
    Bokhari AA; Syed V
    J Cell Biochem; 2015 Aug; 116(8):1797-805. PubMed ID: 25683036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
    Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
    Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of SIRT7 on inhibiting the epithelial-mesenchymal transformation in pancreatic cancer cells and related mechanism].
    Wang MD; Gao TY; Huang W; Yang YK; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):566-582. PubMed ID: 38880736
    [No Abstract]   [Full Text] [Related]  

  • 46. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.
    Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y
    Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
    Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
    J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indomethacin prevents TGF-β-induced epithelial-to-mesenchymal transition in pancreatic cancer cells; evidence by Raman spectroscopy.
    Sezer G; Onses MS; Sakir M; Sahin F; Çamdal A; Sezer Z; Inal A; Ciftci Z
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 280():121493. PubMed ID: 35728400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion.
    Nakata K; Ohuchida K; Mizumoto K; Aishima S; Oda Y; Nagai E; Tanaka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S564-74. PubMed ID: 24748127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.
    Sato T; Muramatsu T; Tanabe M; Inazawa J
    Cancer Sci; 2018 Nov; 109(11):3623-3633. PubMed ID: 30156359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
    Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
    Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway.
    Duan W; Li R; Ma J; Lei J; Xu Q; Jiang Z; Nan L; Li X; Wang Z; Huo X; Han L; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Jan; 6(3):1490-506. PubMed ID: 25557170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
    Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
    Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells.
    Guan J; Zhang H; Wen Z; Gu Y; Cheng Y; Sun Y; Zhang T; Jia C; Lu Z; Chen J
    Cancer Lett; 2014 Apr; 345(1):132-9. PubMed ID: 24334138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages.
    Meng F; Li C; Li W; Gao Z; Guo K; Song S
    IUBMB Life; 2014 Dec; 66(12):835-46. PubMed ID: 25557640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.